ZIM Laboratories gains approval to market Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in…
Azithromycin Oral Suspension is differentiated in taste-masked suspension dosage. This is the first marketing authorisation for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ZIm Laboratories
Container shortage affects pharma exports, industry seeks solution
Due to the shortages of containers, exporters are facing 50-60 per cent hike in the freight charges
Pharma industry lauds RBI’s decision to discontinue automatic caution listing
RBI will continue with caution-listing based on case-specific recommendations of the AD bank
ZIM Labs in exclusive licensing agreement with Hypera Pharma for Vitamin D3 orally dispersible films
The product is intended for bone health in infants and the elderly
Pharma cos pay heavy demurrages at ports, CFS authorities supersede govt orders
The Director-General of Shipping had advised ICDs, CFS, shipping lines etc. to not charge, levy or recover any demurrage, ground…
Restrategising to survive and thrive
Anwar Daud, Managing Director, ZIM Laboratories gives an overview of some measures that the government and the industry needs to…